| Name | Title | Contact Details |
|---|
SNBL USA is a part of the SNBL Group of companies and is a subsidiary of Shin Nippon Biomedical Laboratories (SNBL). As part of the SNBL Group, SNBL USA shares the corporate mission statement: We are committed to freeing patients from suffering by
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Lantis Laser Inc is a Denville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
United Medical is a Newark, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medefield is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.